# Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment

> **NCT01423799** · PHASE3 · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 300 (actual)

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Nutritional supplements containing arginine, n-3 and nucleotides
- **DIETARY_SUPPLEMENT:** Isocaloric control

## Key facts

- **NCT ID:** NCT01423799
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2015-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01423799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01423799, "Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01423799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*